Cargando…
Metabolome alterations in severe critical illness and vitamin D status
BACKGROUND: Metabolic homeostasis is substantially disrupted in critical illness. Given the pleiotropic effects of vitamin D, we hypothesized that metabolic profiles differ between critically ill patients relative to their vitamin D status. METHODS: We performed a metabolomics study on biorepository...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532782/ https://www.ncbi.nlm.nih.gov/pubmed/28750641 http://dx.doi.org/10.1186/s13054-017-1794-y |
_version_ | 1783253522487181312 |
---|---|
author | Lasky-Su, Jessica Dahlin, Amber Litonjua, Augusto A. Rogers, Angela J. McGeachie, Michael J. Baron, Rebecca M. Gazourian, Lee Barragan-Bradford, Diana Fredenburgh, Laura E. Choi, Augustine M. K. Mogensen, Kris M. Quraishi, Sadeq A. Amrein, Karin Christopher, Kenneth B. |
author_facet | Lasky-Su, Jessica Dahlin, Amber Litonjua, Augusto A. Rogers, Angela J. McGeachie, Michael J. Baron, Rebecca M. Gazourian, Lee Barragan-Bradford, Diana Fredenburgh, Laura E. Choi, Augustine M. K. Mogensen, Kris M. Quraishi, Sadeq A. Amrein, Karin Christopher, Kenneth B. |
author_sort | Lasky-Su, Jessica |
collection | PubMed |
description | BACKGROUND: Metabolic homeostasis is substantially disrupted in critical illness. Given the pleiotropic effects of vitamin D, we hypothesized that metabolic profiles differ between critically ill patients relative to their vitamin D status. METHODS: We performed a metabolomics study on biorepository samples collected from a single academic medical center on 65 adults with systemic inflammatory response syndrome or sepsis treated in a 20-bed medical ICU between 2008 and 2010. To identify key metabolites and metabolic pathways related to vitamin D status in critical illness, we first generated metabolomic data using gas and liquid chromatography mass spectroscopy. We followed this by partial least squares-discriminant analysis to identify individual metabolites that were significant. We then interrogated the entire metabolomics profile using metabolite set enrichment analysis to identify groups of metabolites and pathways that were differentiates of vitamin D status. Finally we performed logistic regression to construct a network model of chemical-protein target interactions important in vitamin D status. RESULTS: Metabolomic profiles significantly differed in critically ill patients with 25(OH)D ≤ 15 ng/ml relative to those with levels >15 ng/ml. In particular, increased 1,5-anhydroglucitol, tryptophan betaine, and 3-hydroxyoctanoate as well as decreased 2-arachidonoyl-glycerophosphocholine and N-6-trimethyllysine were strong predictors of 25(OH)D >15 ng/ml. The combination of these five metabolites led to an area under the curve for discrimination for 25(OH)D > 15 ng/ml of 0.82 (95% CI 0.71–0.93). The metabolite pathways related to glutathione metabolism and glutamate metabolism are significantly enriched with regard to vitamin D status. CONCLUSION: Vitamin D status is associated with differential metabolic profiles during critical illness. Glutathione and glutamate pathway metabolism, which play principal roles in redox regulation and immunomodulation, respectively, were significantly altered with vitamin D status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1794-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5532782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55327822017-08-02 Metabolome alterations in severe critical illness and vitamin D status Lasky-Su, Jessica Dahlin, Amber Litonjua, Augusto A. Rogers, Angela J. McGeachie, Michael J. Baron, Rebecca M. Gazourian, Lee Barragan-Bradford, Diana Fredenburgh, Laura E. Choi, Augustine M. K. Mogensen, Kris M. Quraishi, Sadeq A. Amrein, Karin Christopher, Kenneth B. Crit Care Research BACKGROUND: Metabolic homeostasis is substantially disrupted in critical illness. Given the pleiotropic effects of vitamin D, we hypothesized that metabolic profiles differ between critically ill patients relative to their vitamin D status. METHODS: We performed a metabolomics study on biorepository samples collected from a single academic medical center on 65 adults with systemic inflammatory response syndrome or sepsis treated in a 20-bed medical ICU between 2008 and 2010. To identify key metabolites and metabolic pathways related to vitamin D status in critical illness, we first generated metabolomic data using gas and liquid chromatography mass spectroscopy. We followed this by partial least squares-discriminant analysis to identify individual metabolites that were significant. We then interrogated the entire metabolomics profile using metabolite set enrichment analysis to identify groups of metabolites and pathways that were differentiates of vitamin D status. Finally we performed logistic regression to construct a network model of chemical-protein target interactions important in vitamin D status. RESULTS: Metabolomic profiles significantly differed in critically ill patients with 25(OH)D ≤ 15 ng/ml relative to those with levels >15 ng/ml. In particular, increased 1,5-anhydroglucitol, tryptophan betaine, and 3-hydroxyoctanoate as well as decreased 2-arachidonoyl-glycerophosphocholine and N-6-trimethyllysine were strong predictors of 25(OH)D >15 ng/ml. The combination of these five metabolites led to an area under the curve for discrimination for 25(OH)D > 15 ng/ml of 0.82 (95% CI 0.71–0.93). The metabolite pathways related to glutathione metabolism and glutamate metabolism are significantly enriched with regard to vitamin D status. CONCLUSION: Vitamin D status is associated with differential metabolic profiles during critical illness. Glutathione and glutamate pathway metabolism, which play principal roles in redox regulation and immunomodulation, respectively, were significantly altered with vitamin D status. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1794-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-28 /pmc/articles/PMC5532782/ /pubmed/28750641 http://dx.doi.org/10.1186/s13054-017-1794-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lasky-Su, Jessica Dahlin, Amber Litonjua, Augusto A. Rogers, Angela J. McGeachie, Michael J. Baron, Rebecca M. Gazourian, Lee Barragan-Bradford, Diana Fredenburgh, Laura E. Choi, Augustine M. K. Mogensen, Kris M. Quraishi, Sadeq A. Amrein, Karin Christopher, Kenneth B. Metabolome alterations in severe critical illness and vitamin D status |
title | Metabolome alterations in severe critical illness and vitamin D status |
title_full | Metabolome alterations in severe critical illness and vitamin D status |
title_fullStr | Metabolome alterations in severe critical illness and vitamin D status |
title_full_unstemmed | Metabolome alterations in severe critical illness and vitamin D status |
title_short | Metabolome alterations in severe critical illness and vitamin D status |
title_sort | metabolome alterations in severe critical illness and vitamin d status |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532782/ https://www.ncbi.nlm.nih.gov/pubmed/28750641 http://dx.doi.org/10.1186/s13054-017-1794-y |
work_keys_str_mv | AT laskysujessica metabolomealterationsinseverecriticalillnessandvitamindstatus AT dahlinamber metabolomealterationsinseverecriticalillnessandvitamindstatus AT litonjuaaugustoa metabolomealterationsinseverecriticalillnessandvitamindstatus AT rogersangelaj metabolomealterationsinseverecriticalillnessandvitamindstatus AT mcgeachiemichaelj metabolomealterationsinseverecriticalillnessandvitamindstatus AT baronrebeccam metabolomealterationsinseverecriticalillnessandvitamindstatus AT gazourianlee metabolomealterationsinseverecriticalillnessandvitamindstatus AT barraganbradforddiana metabolomealterationsinseverecriticalillnessandvitamindstatus AT fredenburghlaurae metabolomealterationsinseverecriticalillnessandvitamindstatus AT choiaugustinemk metabolomealterationsinseverecriticalillnessandvitamindstatus AT mogensenkrism metabolomealterationsinseverecriticalillnessandvitamindstatus AT quraishisadeqa metabolomealterationsinseverecriticalillnessandvitamindstatus AT amreinkarin metabolomealterationsinseverecriticalillnessandvitamindstatus AT christopherkennethb metabolomealterationsinseverecriticalillnessandvitamindstatus |